Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen.

Demetriou SK, Ona-Vu K, Sullivan EM, Dong TK, Hsu SW, Oh DH.

Int J Cancer. 2012 Oct 15;131(8):1818-27. doi: 10.1002/ijc.27440. Epub 2012 May 29.

2.

The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.

Amber K, McLeod MP, Nouri K.

Dermatol Surg. 2013 Feb;39(2):232-8. doi: 10.1111/dsu.12079. Review.

PMID:
23387356
3.

Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential.

Spurgeon ME, Lambert PF.

Virology. 2013 Jan 5;435(1):118-30. doi: 10.1016/j.virol.2012.09.029. Review.

4.

MCV and Merkel cell carcinoma: a molecular success story.

Arora R, Chang Y, Moore PS.

Curr Opin Virol. 2012 Aug;2(4):489-98. doi: 10.1016/j.coviro.2012.05.007. Epub 2012 Jun 17. Review.

5.

Merkel cell carcinoma: a virus-induced human cancer.

Chang Y, Moore PS.

Annu Rev Pathol. 2012;7:123-44. doi: 10.1146/annurev-pathol-011110-130227. Epub 2011 Sep 13. Review.

6.

[Merkel cell carcinoma revisited: a new example of viro-induced human tumour].

Sastre-Garau X.

Pathol Biol (Paris). 2011 Apr;59(2):127-30. doi: 10.1016/j.patbio.2010.07.007. Review. French.

PMID:
20817373
7.

[Merkel cell polyomavirus and Merkel cell carcinoma].

Nakamura T, Katano H.

Uirusu. 2009 Jun;59(1):37-42. Review. Japanese.

8.

Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

Vandeven N, Nghiem P.

Immunotherapy. 2016 Jul;8(8):907-21. doi: 10.2217/imt-2016-0009. Review.

PMID:
27381685
9.

Merkel cell carcinoma: recent insights and new treatment options.

Schrama D, Ugurel S, Becker JC.

Curr Opin Oncol. 2012 Mar;24(2):141-9. doi: 10.1097/CCO.0b013e32834fc9fe. Review.

PMID:
22234254
10.

Large T and small T antigens of Merkel cell polyomavirus.

Wendzicki JA, Moore PS, Chang Y.

Curr Opin Virol. 2015 Apr;11:38-43. doi: 10.1016/j.coviro.2015.01.009. Epub 2015 Feb 11. Review.

11.

Update on human polyomaviruses and cancer.

Gjoerup O, Chang Y.

Adv Cancer Res. 2010;106:1-51. doi: 10.1016/S0065-230X(10)06001-X. Review.

PMID:
20399955
12.

T antigen transgenic mouse models.

Sáenz Robles MT, Pipas JM.

Semin Cancer Biol. 2009 Aug;19(4):229-35. doi: 10.1016/j.semcancer.2009.02.002. Epub 2009 Feb 14. Review.

13.

Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Fluck MM, Schaffhausen BS.

Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents. doi: 10.1128/MMBR.00009-09. Review.

14.

The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer.

Moens U, Rasheed K, Abdulsalam I, Sveinbjørnsson B.

Viruses. 2015 Apr 10;7(4):1871-901. doi: 10.3390/v7041871. Review.

15.

Immunity to polyomavirus infection: the polyomavirus-mouse model.

Swanson PA 2nd, Lukacher AE, Szomolanyi-Tsuda E.

Semin Cancer Biol. 2009 Aug;19(4):244-51. doi: 10.1016/j.semcancer.2009.02.003. Epub 2009 Feb 14. Review.

16.

Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?

Minocha R, Damian DL, Halliday GM.

Photodermatol Photoimmunol Photomed. 2017 Jul 5. doi: 10.1111/phpp.12328. [Epub ahead of print] Review.

PMID:
28681504
17.

Strategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome Subtraction.

Mirvish ED, Shuda M.

Front Microbiol. 2016 May 13;7:676. doi: 10.3389/fmicb.2016.00676. eCollection 2016. Review.

Supplemental Content

Support Center